Advanced Molecular Research on Retinopathy and Protection
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 September 2025 | Viewed by 1596
Special Issue Editor
Interests: retina; aged macular degeneration; diabetic retinopathy; retinal disease; retinal vascular disease
Special Issue Information
Dear Colleagues,
Retinopathy encompasses a range of retinal disorders characterized by damage to the retina, often resulting in vision impairment. Understanding the molecular mechanisms underlying different types of retinopathy is crucial for developing effective protective strategies. This research explores the pathophysiology, molecular targets, and potential interventions for several forms of retinopathy, including diabetic retinopathy, age-related macular degeneration (AMD), and various retinopathies.
Recent advancements in the protection and treatment of retinopathy focus on innovative therapies, lifestyle modifications, and emerging technologies. Ongoing research and innovations in pharmacotherapy, gene therapy, nutritional strategies, and lifestyle modifications are enhancing protection against various forms of retinopathy. These developments aim to improve patient outcomes and preserve vision through a multifaceted approach to prevention and treatment.
In addition to the content mentioned, studies related to retinopathy and protection are welcome for publication in this Special Issue. We hope that this Issue will contribute to the work of many researchers in the field.
Dr. Jaeyon Won
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- retinopathy
- neuroprotection
- antioxidants
- innovative therapy
- emerging technology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
